Folke Schmidt

2.3k total citations
18 papers, 1.9k citations indexed

About

Folke Schmidt is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Folke Schmidt has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Folke Schmidt's work include Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers) and Urological Disorders and Treatments (3 papers). Folke Schmidt is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers) and Urological Disorders and Treatments (3 papers). Folke Schmidt collaborates with scholars based in Germany, United States and Switzerland. Folke Schmidt's co-authors include Volker Breu, Dominik N. Müller, Friedrich C. Luft, Eero Mervaala, Detlev Ganten, Joon-Keun Park, Hermann Haller, Ralf Dechend, Anette Fiebeler and Jürgen Theuer and has published in prestigious journals such as Cancer Research, Hypertension and The Journal of Urology.

In The Last Decade

Folke Schmidt

17 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Folke Schmidt Germany 12 612 611 602 507 292 18 1.9k
Max H. Stickland United Kingdom 25 313 0.5× 716 1.2× 374 0.6× 605 1.2× 396 1.4× 50 2.5k
Samir S. El‐Dahr United States 33 1.7k 2.9× 542 0.9× 963 1.6× 630 1.2× 185 0.6× 127 3.2k
Stefan-Martin Herrmann Germany 21 478 0.8× 158 0.3× 574 1.0× 398 0.8× 374 1.3× 24 1.9k
Philipp Stawowy Germany 28 825 1.3× 171 0.3× 743 1.2× 310 0.6× 401 1.4× 90 2.3k
Roger Kranzhöfer Germany 15 418 0.7× 181 0.3× 681 1.1× 199 0.4× 411 1.4× 23 1.9k
Masayuki Hosoi Japan 19 472 0.8× 222 0.4× 366 0.6× 300 0.6× 117 0.4× 42 1.4k
Bernd Klanke Germany 25 692 1.1× 213 0.3× 312 0.5× 189 0.4× 412 1.4× 40 1.7k
Jan‐Willem N. Akkerman Netherlands 26 580 0.9× 176 0.3× 553 0.9× 272 0.5× 112 0.4× 59 1.9k
Daisuke Ogawa Japan 22 793 1.3× 154 0.3× 214 0.4× 816 1.6× 212 0.7× 51 2.2k
Jason Gay United States 18 653 1.1× 120 0.2× 425 0.7× 415 0.8× 309 1.1× 30 1.6k

Countries citing papers authored by Folke Schmidt

Since Specialization
Citations

This map shows the geographic impact of Folke Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Folke Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Folke Schmidt more than expected).

Fields of papers citing papers by Folke Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Folke Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Folke Schmidt. The network helps show where Folke Schmidt may publish in the future.

Co-authorship network of co-authors of Folke Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Folke Schmidt. A scholar is included among the top collaborators of Folke Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Folke Schmidt. Folke Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Salami, Simpa S., Folke Schmidt, Bharathi Laxman, et al.. (2011). Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Urologic Oncology Seminars and Original Investigations. 31(5). 566–571. 163 indexed citations
2.
Gillitzer, Rolf, Christian Thomas, Christoph Wiesner, et al.. (2009). Single Center Comparison of Anastomotic Strictures After Radical Perineal and Radical Retropubic Prostatectomy. Urology. 76(2). 417–422. 32 indexed citations
3.
Thomas, Christian, Christoph Wiesner, Sebastian Melchior, et al.. (2008). Urokinase‐plasminogen‐activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer. British Journal of Urology. 104(1). 29–34. 20 indexed citations
4.
Gillitzer, Rolf, Sascha Pahernik, Christian Hampel, et al.. (2008). THERAPY CHOICES OF 1600 UROLOGISTS AND RADIOONCOLOGISTS IF PERSONALLY DIAGNOSED WITH LOCALIZED PROSTATE CANCER (PCa). The Journal of Urology. 179(4S). 399–399. 3 indexed citations
5.
Thomas, Christian, Christoph Wiesner, Sebastian Melchior, et al.. (2008). Indications for Preoperative Prostate Biopsy in Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer. The Journal of Urology. 180(5). 1938–1941. 5 indexed citations
6.
Schmidt, Folke, Kirsten D. Mertz, Sven Perner, et al.. (2008). ERG EXPRESSION VARIES IN DIFFERENT ISOFORMS OF TMPRSS2:ERG GENE FUSION IN PROSTATE CANCER. The Journal of Urology. 179(4S). 393–393.
7.
Perner, Sven, Folke Schmidt, Matthias D. Hofer, Rainer Kuefer, & Mark A. Rubin. (2007). Die TMPRSS2-ETS-Genfusion beim Prostatakarzinom. Der Urologe. 46(7). 754–760. 7 indexed citations
8.
Perner, Sven, Francesca Demichelis, Rameen Beroukhim, et al.. (2006). TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer. Cancer Research. 66(17). 8337–8341. 388 indexed citations
9.
Fiebeler, Anette, Folke Schmidt, Dominik N. Müller, et al.. (2001). Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-κB Activation in Angiotensin II–Induced Cardiac Injury. Hypertension. 37(2). 787–793. 172 indexed citations
10.
Dechend, Ralf, Anette Fiebeler, Joon-Keun Park, et al.. (2000). Amelioration of Angiotensin Ii-Induced Cardiac Injury by Hmg-Coa Reductase Inhibition. Hypertension. 36. 683–683. 2 indexed citations
11.
Mervaala, Eero, Dominik N. Müller, Joon-Keun Park, et al.. (2000). Cyclosporin A Protects Against Angiotensin II–Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen Genes. Hypertension. 35(1). 360–366. 62 indexed citations
12.
Müller, Dominik N., Eero Mervaala, Ralf Dechend, et al.. (2000). Angiotensin II (AT1) Receptor Blockade Reduces Vascular Tissue Factor in Angiotensin II-Induced Cardiac Vasculopathy. American Journal Of Pathology. 157(1). 111–122. 86 indexed citations
13.
Müller, Dominik N., Ralf Dechend, Eero Mervaala, et al.. (2000). NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats. Hypertension. 35(1). 193–201. 326 indexed citations
14.
Müller, Dominik N., Eero Mervaala, Folke Schmidt, et al.. (2000). Effect of Bosentan on NF-κB, Inflammation, and Tissue Factor in Angiotensin II–Induced End-Organ Damage. Hypertension. 36(2). 282–290. 127 indexed citations
15.
Mervaala, Eero, Dominik N. Müller, Folke Schmidt, et al.. (2000). Blood Pressure–Independent Effects in Rats With Human Renin and Angiotensinogen Genes. Hypertension. 35(2). 587–594. 111 indexed citations
16.
Mervaala, Eero, Dominik N. Müller, Joon-Keun Park, et al.. (1999). Monocyte Infiltration and Adhesion Molecules in a Rat Model of High Human Renin Hypertension. Hypertension. 33(1). 389–395. 187 indexed citations
17.
Luft, Friedrich C., Eero Mervaala, Dominik N. Müller, et al.. (1999). Hypertension-Induced End-Organ Damage. Hypertension. 33(1). 212–218. 167 indexed citations
18.
Faraj, Bahjat A., et al.. (1987). Tyramine neurotoxicity and first-pass brain technetium-99m-diethylenetriamine penta-acetic acid.. Journal of Pharmacology and Experimental Therapeutics. 241(1). 42–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026